XML 86 R77.htm IDEA: XBRL DOCUMENT
v3.23.3

Joint Venture - Schedule of Deferred Intra Entity Profit Margin from Sales (Details) - USD ($) $ in Thousands | 3 Months Ended
--- | ---
Sep. 30, 2023 | Sep. 30, 2022
Schedule of Equity Method Investments [Line Items] |  |
Total change in deferred intra-entity profit margin from sales | $ 1,576 | $ 39
Joint venture |  |
Schedule of Equity Method Investments [Line Items] |  |
Previously deferred intra-entity profit margin from sales - recognized | (1,585) | (2,348)
Intra-entity profit margin from sales - deferred | 3,161 | 2,387
Total change in deferred intra-entity profit margin from sales | $ 1,576 | $ 39

X
- Definition Equity method investments deferred of intra entity profit margin from sales. + References No definition available. + Details
Name: | aray_EquityMethodInvestmentsDeferredOfIntraEntityProfitMarginFromSales
Namespace Prefix: | aray_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity method investments previously deferred of intra entity margin on sales. + References No definition available. + Details
Name: | aray_EquityMethodInvestmentsPreviouslyDeferredOfIntraEntityMarginOnSales
Namespace Prefix: | aray_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Income loss from equity method investments deferral of intra entity profit margin from sales. + References No definition available. + Details
Name: | aray_IncomeLossFromEquityMethodInvestmentsDeferralOfIntraEntityProfitMarginFromSales
Namespace Prefix: | aray_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aray_JointVentureMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |